This trial is testing a new way to provide care for rectal cancer survivors that includes regular meetings with oncology nurses, enhanced communication among all their doctors, and education for patients about late and long-term effects of cancer.
1 Primary · 3 Secondary · Reporting Duration: Baseline, 3, and 6 months after study start
Active Control
Experimental Treatment
80 Total Participants · 2 Treatment Groups
Primary Treatment: Survivorship Care Initiative · No Placebo Group · N/A
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: